期刊文献+

中性粒细胞明胶酶相关脂质运载蛋白在代谢相关肾损伤中的应用价值分析 被引量:4

Application value of neutrophil gelatinase related lipid carrier protein in metabolism related renal injury
原文传递
导出
摘要 中性粒细胞明胶酶相关脂质运载蛋白(neutrophil gelatinase-associated lipocalin, NGAL)作为一类新发现的脂肪细胞因子, 广泛存在于机体发生代谢异常时的病变组织细胞内。大量动物及临床试验证实, NGAL可在肝脏、肾脏、心脏、胰腺、前列腺及上皮细胞等多种组织中微表达, 在肥胖-炎症-代谢综合征及其引起的胰岛素抵抗、各种慢性肾病、心脑血管疾病、炎性反应及肿瘤等疾病中参与机体生理病理过程, 本文主要针对NGAL与代谢相关肾损伤的关系进行综述, 为临床的预防、早期诊断和治疗提供依据。 Neutrophil gelati-nase associated lipocalin(NGAL),as a newly discovered adipocytokines,widely exists in the cells of diseased tissues when metabolic abnormalities occur.A large number of animal and clinical trials have confirmed that NGAL can be expressed in trace amounts in various tissues such as liver,kidney,heart,pancreas,prostate and epithelial cells,and participate in the physiological and pathological process of obesity inflammation metabolism syndrome and its induced insulin resistance,various chronic kidney diseases,cardiovascular and cerebrovascular diseases,inflammatory response and tumors.This article mainly reviews the association between NGAL and metabolism related kidney injury,so as to provide basis for clinical prevention,early diagnosis and treatment.
作者 赵耕 牛文彦 Zhao Geng;Niu Wenyan(Department of Laboratory,NHC Key Laboratory of Hormones and Development,Tianjin Key Laboratory of Metabolic Diseases,Chu Hsien-I Memorial Hospital&Tianjin Institute of Endocrinology,Tianjin Medical University,Tianjin 300134,China;Department of Laboratory,Tibet Autonomous Region Changdu Tibetan Hospital,Changdu 854000,China)
出处 《国际内分泌代谢杂志》 2022年第4期272-275,共4页 International Journal of Endocrinology and Metabolism
基金 西藏自治区自然科学基金项目(XZ2019ZRG-143)。
关键词 中性粒细胞明胶酶相关脂质运载蛋白 糖尿病肾脏病 高尿酸 肥胖 肾损伤 Neutrophil gelatinase-associated lipid carrier protein Diabetic kidney disease High uric acid Obesity Kidney injury
  • 相关文献

参考文献3

二级参考文献36

  • 1Kikkawa R, Koya D, Haneda M. Progression of diabetic nephropathy[J]. Am J Kidney Dis, 2003,41 (3 Suppl 1 ) : 19- 21.
  • 2Fioretto P,Steffes M W,Sutherland D E,et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation[J]. N Engl J Med,1998,339(2) :69-75.
  • 3Brownlee M, Cerami A,Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications[J]. N Engl J Med, 1988,318(20) :1315-1321.
  • 4Yamagishi S, TakeuchiM, Inagaki Y, et al. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy [J]. Int J Clin Pharmacol Res,2003,23(4) : 129-134.
  • 5Kumar D,Robertson S,Bum K D. Evidence of apoptosis in human diabetic kidney[J]. Mol Cell Biochem,2004,259(1-2):67-70.
  • 6Sakurai K,Cominacini L,Garbin U,et al. Induction of endothelin-1 production in endothelial cells via co-operative action between CD40 and lectin - like oxidized LDL receptor( LOX-1 )[J]. J Cardiovasc Pharmacol, 2004,44 ( 11 ):S173-S180.
  • 7Prabhakk S S. Role of nitric oxide in diabetic nephropathy[J]. Curr Diab Rep,2005,5(6) :449-454.
  • 8Matsumoto K, Nakamura T. Hepatocyte growth factor, renotropic role and potential therapeutics for renal diseases[J]. Kidney Int, 2001,59(6) : 2023-2038.
  • 9Tuttle K R. Liking metabolism and immunology: diabetic nephropathy is an inflammatory disease[J]. J Am Soc Nephrol, 2005,16(6) : 1537-1538.
  • 10Haslinger B, Mand-weber glucose concentration S, Sellmager A, et al. Effect of high on the synthesis of monocyte chemoattractant protein-1 in human perineal mesothelial cells: involvement of protein kinase C[J]. Nephron, 2001,87 (4):346-351.

共引文献43

同被引文献46

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部